Welcome to our dedicated page for QT Imaging Holdings news (Ticker: qti), a resource for investors and traders seeking the latest updates and insights on QT Imaging Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect QT Imaging Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of QT Imaging Holdings's position in the market.
QT Imaging Holdings (NASDAQ:QTI) announces the expansion of its Breast Acoustic CT™ Scanner to Vitality Renewal Functional Medicine in Crystal Lake, Illinois. Dr. Yvonne Karney, the founder, expresses excitement about offering this FDA-cleared, non-invasive 3D breast imaging technology in the Chicagoland area. The QTscan™ provides detailed images without compression or radiation and is more accurate than mammography and hand-held ultrasound for certain breast structures. Dr. Karney highlights the limitations of mammography, especially for women with dense breasts, and emphasizes the importance of offering women alternative screening options. QTI's CEO, Dr. Raluca Dinu, reaffirms the company's commitment to expanding access to their breast imaging technology nationwide.
QT Imaging Holdings (NASDAQ: QTI) reported financial results for Q2 2024:
- Generated $1.7 million in scanner sales revenue with a 51% gross margin
- Net loss of $1.2 million, including $2.1 million non-cash income from fair value changes
- Non-GAAP Adjusted EBITDA of $(2.1) million
Key developments:
- Signed U.S. exclusive distribution agreement with NXC Imaging
- Partnered with University of Oklahoma and OU Health Stephenson Cancer Center
- Delivered four Breast Acoustic CT scanners, expanding to five commercial locations
- Published study showing accurate visualization of breast tissue using QT technology
Outlook: Expects similar revenue pace in H2 2024 with higher gross margins
QT Imaging Holdings (NASDAQ:QTI) has announced a partnership with PerfeQTion Imaging Center in Haverford, Pennsylvania, shipping their Breast Acoustic CT™ Scanner to the facility. Founded by Dr. Jennifer Simmons, PerfeQTion Imaging™ Center offers screening, diagnostic exams, and monitoring services. The QTI technology provides a safe, painless, and accurate alternative for breast imaging, without the use of radiation.
Dr. Simmons believes this technology will revolutionize breast cancer screening, especially for young and high-risk women who are more susceptible to radiation damage. QTI's CEO, Dr. Raluca Dinu, emphasized that their technology is expanding medical imaging opportunities beyond traditional settings, supporting direct-to-provider approaches to lower healthcare costs and increase access.
QT Imaging Holdings (NASDAQ:QTI) has partnered with the University of Oklahoma and OU Health Stephenson Cancer Center to advance medical imaging research. The collaboration aims to enhance cancer detection and treatment using QT Imaging's Breast Acoustic CT™ technology. This pioneering imaging system offers quantitative imaging predictive markers to improve diagnostic precision and consistency. The University of Oklahoma's imaging center, a National Cancer Institute-designated facility, will leverage this technology in its innovative research initiatives. Furthermore, the collaboration will explore AI and ML-based algorithms to streamline clinical workflows and extract more insights from the imaging data. Dr. Javier Jo, Director at OU, and Dr. Bilal Malik, QTI’s Chief Science Officer, both emphasize the potential of this partnership to transform cancer care and develop new technological avenues in breast cancer research.
QT Imaging Holdings, Inc. (NASDAQ: QTI) reported revenue of $1.4 million in Q1 2024, with a 56% gross margin. The company streamlined operations through a strategic sales partnership in the USA and completed a merger with GigCapital5. A blinded screening trial confirmed the efficacy of QTI technology. Financially, while revenue increased significantly, the net loss was $4.3 million, including non-cash income related to the merger. The company also announced key partnerships and leadership updates, aiming for continued growth in 2024.
QT Imaging Holdings, Inc. (NASDAQ:QTI) partners with The Vincere Cancer Center in Scottsdale, AZ, renowned for cancer prevention, early detection, and innovative cancer services. The center's founders, Dr. Shukla and Dr. Prichard, focus on superior cancer care with precision technology. The partnership aims to redefine standards of care in breast cancer detection, offering accessible and accurate screening solutions.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of QT Imaging Holdings (qti)?
What is the market cap of QT Imaging Holdings (qti)?
